Hempacco Co., Inc.
Market Cap
$1.19K
P/E Ratio
—
EPS
$-4.70
Dividend Yield
0.00%
52-Week Range
$0.00 — $0.05
Volume
382
Avg Volume
378
Beta
2.62
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.00
P/S (TTM)
0.00
P/B (TTM)
-0.00
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-3.60%
ROA (TTM)
-0.73%
ROIC
—
Gross Margin
-0.30%
Operating Margin
-2.18%
Net Margin
—
Debt/Equity
-37.31
Current Ratio
0.25
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-1.05%
EPS Growth (5Y)
-6.55%
Sales Growth (3Y)
+1.60%
Sales Growth (5Y)
+0.96%
EPS Est (This Year)
—
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.39
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
5.92M
Float
2.93M
Free Float %
49.55%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
Exchange
NASDAQ
IPO Date
2022-08-30
Employees
12
CEO
Sandro Piancone
Index Membership
—
Website
https://hempaccoinc.com
Hempacco Co., Inc. (HPCO) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $1.19K, HPCO is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare HPCO against other stocks using dozens of fundamental and technical filters.
No, Hempacco Co., Inc. (HPCO) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Hempacco Co., Inc. (HPCO) has a market capitalization of $1,185, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.